BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
219 hedge funds and large institutions have $3.25B invested in Blueprint Medicines in 2023 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 97 increasing their positions, 55 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
19% less capital invested
Capital invested by funds: $4.03B → $3.25B (-$780M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
67% less call options, than puts
Call options by funds: $13.3M | Put options by funds: $40.4M
Holders
219
Holding in Top 10
3
Calls
$13.3M
Puts
$40.4M
Top Buyers
| 1 | +$31.3M | |
| 2 | +$29.9M | |
| 3 | +$27.1M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$25M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$16.9M |
Top Sellers
| 1 | -$114M | |
| 2 | -$31.3M | |
| 3 | -$21M | |
| 4 |
CC
Casdin Capital
New York
|
-$12.5M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.37M |